Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
US Department of Health and Human Services.

Video. Second Alzheimer's slowing drug to seek approval in the US

Updated:

Donanemab has proven to slow disease progression by several months in some patients but has also shown serious side effects.

Read full article
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT